Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Scancell and Celltech collaborate on antibody therapeutics to Lewis(y/b)

Aug. 11, 2003

GPC Biotech makes progress on various fronts with 1D09C3

Aug. 6, 2003

Grant supports development of cancer vaccines at Epimmune using analogue epitopes

Aug. 1, 2003

Phase II trial indicates promising efficacy for alemtuzumab in MF/SS

July 31, 2003

Anti-gp75 antibodies evaluated as potential therapies for melanoma

July 25, 2003

BMS evaluates the potential of agonist antibodies targeting CD137 for antitumor therapy

July 24, 2003

Further positive results reported from phase Ib trial of Cancer Vac immunotherapy

July 23, 2003

Early completion anticipated for pivotal R-1549 trial

July 21, 2003

MEDI-507 proven effective in a murine model of adult T-cell leukemia

July 15, 2003

MDX-010 combined with tumor vaccines in metastatic melanoma

July 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.